Evidence map›Paper›PMID 36132563›Full record

ArticleNanoscale advances2021

Hybrid chemoenzymatic heterogeneous catalyst prepared in one step from zeolite nanocrystals and enzyme-polyelectrolyte complexes.

Margot Van der Verren, Valentin Smeets, Aurélien Vander Straeten, Christine Dupont-Gillain, Damien P Debecker

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nanoscale advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Margot Van der VerrenInstitute of Condensed Matter and Nanosciences, UCLouvain Place Louis Pasteur 1 1348 Louvain-la-Neuve Belgium damien.debecker@uclouvain.be.ORCID https://orcid.org/0000-0002-4424-2234
Valentin SmeetsInstitute of Condensed Matter and Nanosciences, UCLouvain Place Louis Pasteur 1 1348 Louvain-la-Neuve Belgium damien.debecker@uclouvain.be.ORCID https://orcid.org/0000-0002-4661-0424
Aurélien Vander StraetenInstitute of Condensed Matter and Nanosciences, UCLouvain Place Louis Pasteur 1 1348 Louvain-la-Neuve Belgium damien.debecker@uclouvain.be.ORCID https://orcid.org/0000-0002-5435-1987
Christine Dupont-GillainInstitute of Condensed Matter and Nanosciences, UCLouvain Place Louis Pasteur 1 1348 Louvain-la-Neuve Belgium damien.debecker@uclouvain.be.ORCID https://orcid.org/0000-0002-6153-4044
Damien P DebeckerInstitute of Condensed Matter and Nanosciences, UCLouvain Place Louis Pasteur 1 1348 Louvain-la-Neuve Belgium damien.debecker@uclouvain.be.ORCID https://orcid.org/0000-0001-6500-2996
Institut des Arts de Diffusion · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The combination of inorganic heterogeneous catalysts and enzymes, in so-called hybrid chemoenzymatic heterogeneous catalysts (HCEHCs), is an attractive strategy to effectively run chemoenzymatic reactions. Yet, the preparation of such bifunctional materials remains challenging because both the inorganic and the biological moieties must be integrated in the same solid, while preserving their intrinsic activity. Combining an enzyme and a zeolite, for example, is complicated because the pores of the zeolite are too small to accommodate the enzyme and a covalent anchorage on the surface is often ineffective. Herein, we developed a new pathway to prepare a nanostructured hybrid catalyst built from glucose oxidase and TS-1 zeolite. Such hybrid material can catalyse the

Identifiers

PMID36132563
PMCPMC9417918
OpenAlexW3128521504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.